Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?

ABSTRACT:

SUBMITTER: Wu J 

PROVIDER: S-EPMC9073773 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature